Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ABL Diagnostics's dividends per share for the
six
months ended in Dec. 2025 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.05. Its Dividend Payout Ratio for the
six
months ended in Dec. 2025 was 0.00. As of today, ABL Diagnostics's Dividend Yield % is 4.70%.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of ABL Diagnostics is 0.82, which seems too high.
Good Sign:
ABL Diagnostics stock Dividend Yield % is close to 1-year high.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
ABL Diagnostics (XPAR:ABLD) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
ABL Diagnostics's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of ABL Diagnostics was 0.82. The lowest was 0.81. And the median was 0.81.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of ABL Diagnostics is 0.82, which seems too high.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
ABL Diagnostics Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
EUR 0.110000
2026-07-03
2026-07-06
2026-07-07
Cash Dividend
annually
EUR:EUR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
ABL Diagnostics's Dividend Yield (%) for Today is calculated as
Current Share Price is €2.34.
ABL Diagnostics's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.11.
During the past 13 years, the highest Dividend Yield of ABL Diagnostics was 4.70%. The lowest was 1.30%. And the median was 1.56%.
Good Sign:
ABL Diagnostics stock Dividend Yield % is close to 1-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABL Diagnostics Dividends per Share Related Terms
ABL Diagnostics Dividends per Share Historical Data
* Premium members only.
The historical data trend for ABL Diagnostics's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ABLD vs VEEV, BTSG, TEM: Dividends per Share Comparison
For the Health Information Services subindustry, ABL Diagnostics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ABL Diagnostics Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where ABL Diagnostics's Dividend Yield % falls into.
ABL Diagnostics (XPAR:ABLD) has a Dividends per Share of €0.05 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on ABL Diagnostics and its competitors.
Is ABL Diagnostics' Dividends per Share too high?
ABL Diagnostics' current Dividends per Share is €0.05. Overall, ABL Diagnostics has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ABL Diagnostics' Dividends per Share compare to VEEV and BTSG?
ABL Diagnostics' Dividends per Share of €0.05 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Healthcare Providers & Services company?
A good Dividends per Share depends on the Healthcare Providers & Services industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on ABL Diagnostics and its competitors. ABL Diagnostics's current Dividends per Share is €0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABL Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, ABL Diagnostics (XPAR:ABLD) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.85, compared to a current price of €2.34 — trading 70.2% below its estimated fair value. The current Dividends per Share is €0.05. ABL Diagnostics' overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For ABL Diagnostics (XPAR:ABLD), the current Dividends per Share is €0.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ABL Diagnostics (XPAR:ABLD) Overvalued in 2026?
Based on GuruFocus' analysis, ABL Diagnostics stock appears to be undervalued.
The current stock price of €2.34 is trading 70.2% below its estimated GF Value™ of €7.85.
GuruFocus considers ABL Diagnostics to be Significantly Undervalued.
Key valuation signals for XPAR:ABLD:
Dividends per Share: €0.05
GF Value™: €7.85 vs. price of €2.34 (70.2% below fair value)
No single metric tells the full story. See the XPAR:ABLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.
50GF Score
Get the complete analysis for XPAR:ABLD
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ABLD has been successfully added to your 
